Fundraising for treatment

Rio is a happy, playful and energetic two-year-old who adores cars and spending time with his big sister Lillyrose! In August 2023, Rio was diagnosed with high-risk neuroblastoma.

Leonardo is a five-year-old from London who loves superheroes and motorcycles. In May 2022, Leonardo was diagnosed with high-risk neuroblastoma and he completed frontline treatment in July 2023 but sadly his disease progressed.

Four-year-old Archie loves Hot Wheels and Paw Patrol. In July 2022, Archie was diagnosed with high-risk neuroblastoma. His family are fundraising £154,000 so he can enrol on the DFMO study in Charlotte once he finishes his frontline treatment in October. This trial is currently not available on the NHS.

Bibi’s family are urgently fundraising to raise £200,000 for Bibi to be treated using CAR T cell therapy in Rome with the hope of getting Bibi back into remission again. This trial is currently not available on the NHS.

Teddy is a four-year-old from West Sussex who is obsessed with anything to do with trains! In July 2022, Teddy was diagnosed with high-risk neuroblastoma.

Flora is an energetic, outdoor-loving five-year-old from East Lothian, Scotland. Her family are continuing to fundraise after Flora sadly relapsed in September 2023 and her total now reflects the new campaign fund total.

Arianna is a beautiful, funny and kind-hearted seven-year-old, who loves dressing up! In November 2021, Arianna was diagnosed with high-risk neuroblastoma. Her family are fundraising £300,000 so she can enrol on the bivalent vaccine clinical trial in New York once she finishes frontline treatment in October. This trial is currently not available on the NHS.

Jessica is the sweetest, kindest three-year-old who loves animals, all things Peppa Pig and playing with her cousin, Maeve. Jessica has high-risk neuroblastoma.

Dulcie is a beautiful and brave six-year-old from Shropshire. She loves My Little Pony, all Disney princesses, rainbows and everything that sparkles! Dulcie was diagnosed with high-risk neuroblastoma in December 2021.

Kayla is a very happy and lively five-year-old from Norwich. She loves Minnie Mouse, Frozen, Peppa Pig and all things pink! Kayla was diagnosed with high-risk neuroblastoma and in November 2022, her end of treatment scans showed disease progression.

Eden is full of life, very cheeky and loved by so many people. Eden is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for Eden’s campaign.

Maysaa is five years old and loves strawberries, unicorns and rainbows. Maysaa enrolled on the DFMO study in Charlotte in August 2022 to continue her treatment, which was made possible by the community of supporters who helped raise the £106,000 needed.

12-year-old Peter is a keen gamer and loves all things Lego and playing Minecraft. Since January 2022, he has been enrolled on the DFMO study in Charlotte, made possible thanks to an incredible community of support for his campaign.

Seven-year-old Poppy loves playing in the park with her friends and her brother. Poppy completed her frontline treatment in October 2022 and scans continue to show no evidence of active disease.

Ashlee is 16 years old and loves music, fashion and her dog, Angel. Ashlee completed the bivalent vaccine clinical trial in December 2021, thanks to the amazing support her campaign received to raise the £239,000 needed.

Katie Rose is a fun-loving, quick-witted, brave 12-year-old girl, who loves making slime, playing Fortnite on her PlayStation, Roblox and Toca Life World and jumping on her trampoline. In March 2018, Katie Rose was diagnosed with high-risk neuroblastoma.

Oliver is described by his dad as the ‘happiest, most fun-loving boy you can imagine – a real joy to be around’. Oliver enrolled on the bivalent vaccine clinical trial in New York in February 2019.

Mikey is seven years old and loves all things dinosaur-related and playing with his little brother, Bobby. Mikey completed the bivalent vaccine clinical trial at Memorial Sloan Kettering Cancer Center in April 2020.